Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,241 total articles
Nanobiotix (NANO) is a specialty biotech with a physics-based radioenhancer platform and an underappreciated royalty engine. The setup today favors a directional long: modest entry risk for substantial upside if near-term clinical/regulatory catalysts and royalty monetization materialize. Trade plan below targets a 45-trading-day horizon with clear…
EZJ (ProShares Ultra MSCI Japan) offers leveraged access to a Japan rally that’s outpacing the U.S. The ETF is trading near $64, sits above short- and medium-term moving averages, and carries a small market cap of $14.08M plus a modest quarterly distribution. This is a tactical, high-risk long trade: entry $64.02, stop $59.00, target $70.50, horizo…
Northland Power's advanced-stage wind and solar projects look materially discounted relative to the probability-weighted cash flows they represent. With several projects at or near financial close and long-term offtake for a sizable portion of expected output, the market has priced in execution failure and higher-for-longer rates. We believe the st…
Silence Therapeutics (SLN) is a $313M market-cap RNA therapeutics company trading near $6.73. We see an asymmetric risk/reward into an August 2026 Divesiran data readout and a recent strategic pivot in the Zerlasiran program. Positive Divesiran data plus a clearer commercialization path for Zerlasiran could fast-track a re-rating versus peers. We r…
Centene (CNC) has moved from a $25 low last year to the mid-$60s on better-than-expected reimbursement dynamics and improving operational leverage. The fundamentals are mixed — negative GAAP EPS and membership headwinds remain — but valuation is compelling and free cash flow is strong. This trade idea targets a measured swing long with clear entry,…
Seneca Foods (SENEA) is a cash-generative packaged-fruit-and-vegetable company trading near its 52-week high after a strong run. At a market cap of roughly $1.14B and free cash flow of $168.5M, the stock looks reasonably valued (PE ~11.5, EV/EBITDA ~7.4). This trade targets continued multiple expansion and frozen-segment recovery over the next 45 t…
L.B. Foster (FSTR) has more than doubled from its 52-week low and is sitting near $42 with accelerating volume, improving margins and free cash flow of $40.5M. The rail and infrastructure end-markets are driving outsized segment growth, and the balance sheet can support further organic growth and shareholder-friendly outcomes. This trade idea outli…
One Stop Systems (OSS) is a niche, high-performance edge compute vendor that just reported a string of defense and commercial wins. With $15M in new bookings (including a $10.5M Navy award), Q1 revenue beat and guidance for 20-25% growth in 2026, the stock is carving out a new growth chapter. This trade idea proposes a long position with a $16.60 e…
Clarus Corporation ($CLAR) is a compact outdoor-equipment operator with recognizable brands, no debt, and a market cap under $120M. That profile creates takeover optionality while the operational picture remains mixed. We lay out a long trade for investors who want to play a potential buyout or a continued operational recovery with a clear entry, s…
Fidelity National Financial (FNF) trades at roughly $47.87 with a market cap near $12.9B, a P/E around 17 and free cash flow of roughly $5.45B. Combine recurring title-insurance margins, accelerating F&G annuities and a reliable quarterly dividend ($0.52) and you get an actionable long setup into 2026. The trade: enter $48.00, stop $43.50, target $…
LightPath Technologies (LPTH) has structural positives — a pivot toward infrared and defense optics, a recent financing that stabilized the balance sheet, and improving technical support above the $14–$16 zone. This trade idea outlines an actionable long with a clear entry at $15.00, a $13.00 stop loss, and a $22.00 target over a 180 trading-day ho…
Comcast (CMCSA) is a mixed fundamental story: secular pressure in broadband subscribers and ad cyclicality in Media, offset by very attractive valuation metrics (P/E ~4.7, P/FCF ~4.2, EV/EBITDA ~4.8) and $20.4B in free cash flow. This trade idea recommends a long entry near $24.32, a conservative stop at $21.50, and a target of $30.00 on a long-ter…
Boston Scientific (BSX) has been punished hard in 2026 despite healthy free cash flow, manageable leverage and tangible product catalysts. The market is pricing the company as a broken compounder; we argue that upcoming clinical readouts and the MiRus TAVR stake provide a credible reset. This is a mid-term swing trade idea with a clearly defined en…
Alphabet's dominant search franchise, expanding cloud footprint, and ongoing AI investments create a compelling risk/reward for a mid-term long. Valuation sits at ~27x earnings with $64.4B in free cash flow and a $4.37T market cap. This trade plan targets a move back toward prior highs while protecting capital if AI spending or macro liquidity pres…
Cellebrite (CLBT) has shown consistent revenue growth, an expanding market opportunity in digital evidence management, and recent insider/institutional confidence. At a $3.16B market cap and modest operational scale, the stock looks actionable from current levels for a long-term trade with defined risk controls.
Nvidia's market price implies continued expansion at peak margins and growth. The order book and recent trading data tell a different story: bearish momentum, heavy short participation, and distribution around rallies. This trade idea lays out a disciplined short with an entry at $204.55, a stop at $218.00, and a target of $170.00 over a mid-term 4…
Cheniere is the incumbent LNG heavyweight: large-scale liquefaction assets, steady free cash flow and a valuation that still rewards growth optionality. Against rising European demand and tight global supply, the setup favors a mid-term long trade into $275 with a strict $230 stop. This is a relative-value call versus smaller, faster-build peers li…
ALVOF is an OTC-listed, speculative energy play trading around $6.35 with constructive technicals and elevated short activity that has recently pulled back. This trade idea treats ALVOF as a high-risk, mid-term swing: enter at $6.35, place a hard stop at $5.25 and target $8.00 over roughly 45 trading days. The thesis leans on a volume-backed breako…
Nordic American Tankers (NAT) offers a compelling income entry today: a $0.22 quarterly payout (9% yield) and a market cap of roughly $1.16B, with insider buying and a fleet growth tailwind. The balance between attractive yield and cyclical shipping risk makes NAT a tactical long for investors comfortable with elevated volatility; this idea lays ou…
Duke Energy ($DUK) looks positioned to grind higher over the next 45 trading days. The stock is trading at $124.77 with a 3.4% yield, P/E around 19, and technical momentum turning constructive. Ongoing utility capital spending tied to AI and data-center growth, an upcoming dividend payment, and a reasonable valuation create a trade with defined ris…
Jones Lang LaSalle (JLL) is a high-quality commercial real estate services and investment manager trading at a reasonable multiple with strong free cash flow and manageable debt. Short-term headlines about AI-driven office demand shifts are creating buying opportunities. Tactical long: entry $300.00, stop $285.00, target $335.00 over a 180 trading-…
AllianceBernstein (AB) trades at roughly $36.75 with a market cap near $3.44B, an annualized cash yield just north of 9%, a P/E around 11, and ROE above 24%. This trade targets income today and modest price appreciation over the next 45 trading days while keeping risk limited with a tight stop below the recent low.
SoftBank Group is a high-conviction asymmetric trade into an AI-led market re-rating. With an OpenAI IPO likely to reset private AI comps and drive liquidity into AI-related assets, SoftBank's portfolio exposure and NAV-linked optionality make it a pragmatic buy into the event. Enter at $50.00, stop at $43.00, target $70.00 across a 45-trading-day …
Simmons First National (SFNC) is showing early signs of a turnaround: improving loan growth, expanding margins called out by investors, a reliable quarterly dividend and a sub-1x price-to-book multiple that discounts better outcomes. This trade idea lays out a mid-term, actionable long with clear entry, stop and target, while acknowledging the comp…
Eikon Therapeutics reported strong ASCO 2026 signals for its lead oncology assets that justify a cautious buy at current levels. With a market cap of roughly $480M, promising early efficacy (63.1% ORR in first-line NSCLC for EIK1001 in combination) and a tight float profile, the stock offers asymmetric upside if follow-up data confirm activity. Tec…
